Prescription visibility
The chemist reads the advised tests, often within minutes of the consultation.
THE LEAD ENGINE
The prescription is already being read at 2.5 lakh+ pharmacies. MargLabz routes it to your lab.
The biggest problem for an independent lab is not software. It is predictable patient flow. MargLabz addresses that by connecting your lab to a network that is already live — not by promising marketing.
Lead volumes depend on your catchment — see the illustration below
2.5 lakh+ countersConsent-firstTerritory-routed
THE PROBLEM
The lead is seen every day. It is never converted.
At the counter today
- The doctor advises the tests; the prescription is at the chemist's counter within minutes
- Nobody there can act on the pathology half of it
- The patient means to get it done — and forgets, or goes to whichever chain advertised loudest
- A handful of referring doctors decide your month, at a commission on every test
- National chains squeeze you on price and on turnaround
- Your analysers and your staff are paid for either way
With the Lead Engine
- The chemist offers the advised test at that counter, on that visit
- The patient opts in there and then — consent recorded before anything reaches your lab
- The lead arrives by the routing rule you set, not by who advertised loudest
- A home collection is booked and the sample is barcoded on pickup
- Demand from your own catchment that you did not have to chase
- Capacity you already pay for, running
What is your lab's capacity utilisation today?
OUR POSITION
We already work at the busiest counter in Indian healthcare.
Trust and proximity
The patient's own neighbourhood relationship — not an advertisement.
Already on Marg
The billing software that chemist opens every morning is ours.
Zero acquisition cost
There is no new network to build. It is live today.
HOW IT WORKS
The MargLabz Lead Engine, step by step.
Five steps, from the prescription on the chemist's counter to a report the patient can actually read.
The chemist reads the advised tests
At a Marg billing counter, often within minutes of the consultation. The pharmacy half of the prescription is dispensed there already; the pathology half is what has had nowhere to go.
THE THREE-SIDED WIN
The lead engine only survives if all three sides win.
The chemist, the lab and the patient each have to gain on the same transaction — or the flow stops within a week.
For the chemist
- Something to offer — the pathology half of the prescription, answered at the same counter
- Nothing to stock or handle — no sample, no reagent, no counter space given up
- A reason the patient returns — the follow-up prescription comes back to the same shop
- Participation on record — every lead the counter raised, attributable and visible
For the lab
- Demand you did not chase — tests a doctor has already advised, in your own catchment
- Capacity that is already paid for — the analyser and the shift run either way
- Less referral dependence — more than a handful of doctors deciding the month
- Routing you control — nearest, preferred or round-robin — per chemist, per territory
- No network to build — the counters are live today; there is nothing to acquire
For the patient
- The test actually gets done — arranged at the counter, not remembered a week later
- Collection at home — a slot they choose, a phlebotomist assigned
- A report they can read — the AI Smart Report in plain language, in eight languages
- Consent they control — opt in at the counter; withdraw it and have the lead deleted
WHAT IT IS WORTH
What the lead engine is worth to a typical lab.
A worked example on conservative assumptions — an illustration, not a projection for your lab.
- Participating chemists in your catchment
- 200
- Leads per chemist per month
- 5
- Leads reaching your lab
- 1,000 / month
- Conversion to a booked test
- 10%
- Booked tests
- 100 / month
- Average ticket size
- ₹800
₹80,000
additional revenue a month, on these assumptions
Conservative illustration only. Actual results depend on your lab's catchment and on chemist participation. No lead volume or revenue outcome is implied or guaranteed.
CONSENT
Consent-first by design, not bolted on later.
The consent step is engineered into the flow rather than added after it, so labs and chemists are covered from the first lead. Referral and incentive structures are being finalised with legal counsel.
Explicit opt-in at capture
The patient agrees at the counter, before any detail reaches a lab.
Purpose limitation
The lead is used to offer the test that was advised — nothing else.
Auditable consent trail
Who consented, to what wording, and when. Recoverable on demand.
Withdrawal and deletion
A patient can withdraw consent and have the lead deleted.
ON THE ROADMAP
MargDocPro — capturing the lead at its source.
One step earlier: the doctor's desk
Marg ERP is also building MargDocPro, a clinic management and EMR system for doctors. When it is live, a lab lead can originate the moment the test is advised — before the prescription is printed. The chemist counter does not change; this adds a second doorway into the same consented flow.
On the roadmap, not available today. Nothing on this page depends on it.
MargDocProDoctor's desk · EMR
MargLabzYour lab
Be an early-adopter lab — and shape the product.
A demo includes a territory review: chemist density and expected lead flow in your own catchment.
No credit card required · Demo in English or Hindi